Advertisement
Home Tags Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Tag: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Link Explored for NSAID Use, Hormonal Contraception, VTE Risk

NSAID use positively linked to VTE, with extra VTE events in those with concomitant high-, medium-risk contraception use

Myorelaxants, NSAIDs, NSAID-Acetaminophen Combo Ease Lower Back Pain

No improvement seen in lower back pain with acetaminophen alone or placebo across trials

ACR: Opioids Raise Risk for VTE in Patients With Rheumatoid Arthritis

However, opioids and NSAIDs carry similar cardiovascular, mortality risks for RA patients

NSAIDs May Interfere With Efficacy of Bisphosphonates

No reduction in osteoporotic fracture risk seen among women receiving concomitant clodronate and NSAIDs

Link Between Analgesics, Incident Tinnitus Explored in Women

No increased risk for tinnitus seen with low-dose aspirin, but increase seen with moderate-dose aspirin for those younger than 60 years, NSAIDS, acetaminophen

NSAID Eye Drops May Suffice for Cataract Surgery Prophylaxis

Initiation of prophylactic treatment three days before surgery is not superior to initiation on day of surgery

Loneliness Linked to Use of High-Risk Meds in Seniors

Loneliness associated with use of NSAIDs, pain medicine, sedatives, anti-anxiety meds, and antidepressants

NSAIDs Better Than Codeine for Outpatient Postoperative Pain

Global assessments at six and 24 hours better with NSAID use, and fewer adverse effects, including bleeding events, reported

NSAID Use Not Linked to Increased Mortality, Severity in COVID-19

In propensity score-matched cohort, no increase seen in in-hospital mortality, critical care admission, requirement for ventilation

The U.S. Food and Drug Administration is requiring labeling changes to nonsteroidal anti-inflammatory drugs that warn of the risks of taking these drugs at 20 weeks of pregnancy or later

FDA Requiring Labeling Changes to NSAIDs Warning of Risks in Pregnancy

Labeling must indicate risks to unborn baby with NSAID use at 20 weeks of pregnancy or later